The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Secretary Change

29 Jun 2015 09:24

RNS Number : 4817R
ABCAM Plc
29 June 2015
 



For immediate release

29 June 2015

ABCAM PLC

("Abcam" or "the Company")

Appointment of Chief Legal Officer and Company Secretary

 

Cambridge UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that it has appointed Suzanne Smith in the new role of Chief Legal Officer and Company Secretary, based at Abcam's headquarters in Cambridge, UK, effective from 6 July 2015. Accordingly, Jeff Iliffe will resign from the role of Company Secretary with effect from the same date.

Suzanne will take responsibility for Abcam's licensing, legal, compliance and company secretary activities. The new role has been created in order to help Abcam achieve its global growth objectives, supporting the Company's partnership and acquisition goals.

Suzanne brings a wealth of experience to Abcam with 20 years' global legal, business and leadership experience within the life science industry. She previously held the role of executive director, legal at Actavis plc, where she had responsibility for the leadership of the legal function internationally. Her prior roles include legal director at Genzyme Therapeutics Ltd, general counsel at Phoqus Pharmaceuticals plc and group legal counsel and company secretary at LGC Ltd. Suzanne is a qualified solicitor and holds an LLB law degree from the University of Exeter and an MBA from the Open University.

Alan Hirzel, CEO of Abcam, commented: "We are delighted to welcome Suzanne to Abcam's leadership team. Suzanne's knowledge and experience within the life sciences industry will be a valuable asset to our company."

 

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Jeff Iliffe, Chief Financial Officer

Laura Taylor, Investor Relations Manager

J.P.Morgan Cazenove - Nominated Adviser & Joint Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Alex Bruce - Nominated Adviser

Peel Hunt LLP - Joint Corporate Broker

+ 44 (0) 20 7418 8900

Clare Terlouw / Jock Maxwell MacDonald - Corporate Broking

 

Notes to Editors

About Abcam

Abcam plc is a provider of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services, multi-language support and next-day delivery in over 130 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM:ABC).

To find out more, please visit www.abcam.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
COSSEESAUFISEEM
Date   Source Headline
14th Dec 20227:00 amRNSCancellation - Abcam Plc
12th Dec 20228:00 amRNSUpdate on AIM Delisting
9th Dec 20225:30 pmRNSAbcam
8th Dec 20222:36 pmRNSHolding(s) in Company
30th Nov 20228:55 amRNSTotal Voting Rights
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
17th Nov 20223:59 pmRNSDirector/PDMR Shareholding
17th Nov 20223:57 pmRNSDirector/PDMR Shareholding
11th Nov 20223:30 pmRNSResult of General Meeting
31st Oct 20223:22 pmRNSTotal Voting Rights
17th Oct 20227:00 amRNSPropose cancellation of AIM shares notice of GM
17th Oct 20227:00 amRNSProposed cancellation of AIM shares & notice of GM
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
10th Oct 20222:01 pmRNSDirector/PDMR Shareholding
10th Oct 20221:59 pmRNSDirector/PDMR Shareholding
30th Sep 20223:50 pmRNSBlock Listing Six Monthly Return
30th Sep 20223:48 pmRNSTotal Voting Rights
12th Sep 202212:00 pmRNSInterim results for the period ended 30 June 2022
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
1st Sep 20222:02 pmRNSAbcam attend Morgan Stanley Healthcare Conference
31st Aug 202211:16 amRNSTotal Voting Rights
17th Aug 20228:30 amRNSNotice of Results
29th Jul 202211:09 amRNSTotal Voting Rights
20th Jul 202212:00 pmRNSTrading Statement
4th Jul 20228:36 amRNSTotal Voting Rights
31st May 20224:22 pmRNSTotal Voting Rights
18th May 20224:30 pmRNSResult of AGM
3rd May 202212:41 pmRNSDirector/PDMR Shareholding
29th Apr 20224:01 pmRNSTotal Voting Rights
5th Apr 20224:35 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSPublication of 2021 ARA and Notice of AGM
31st Mar 202210:58 amRNSTotal Voting Rights
30th Mar 20222:41 pmRNSBlock listing Interim Review
28th Mar 20223:09 pmRNSBlock Listing application of Ordinary Shares
17th Mar 20221:18 pmRNSDirector/PDMR Shareholding Notification
14th Mar 202212:00 pmRNSResults for the period ended 31 December 2021
2nd Mar 20227:00 amRNSTotal Voting Rights
28th Feb 20227:00 amRNSNotice of Full Year Results
4th Feb 202212:02 pmRNSDirector/PDMR Shareholding
31st Jan 202211:49 amRNSTotal Voting Rights
27th Jan 202212:00 pmRNSTrading Statement
31st Dec 202112:49 pmRNSTotal Voting Rights
2nd Dec 20217:00 amRNSUpdate on 2021 General Meeting Resolution Vote
30th Nov 20213:25 pmRNSTotal Voting Rights
12th Nov 20215:28 pmRNSIssue of Equity and Replacement PDMR Notification
12th Nov 20214:17 pmRNSTotal Voting Rights
12th Nov 202112:34 pmRNSIssue of Equity and Replacement PDMR Notification
10th Nov 20214:56 pmRNSIssue of Equity and PDMR Notification
5th Nov 20213:19 pmRNSVesting of All Employee Share Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.